SS Ambade, VK Gupta, RP Bhole, PB Khedekar… - Molecules, 2023 - mdpi.com
Staphylococcus aureus is a common human pathogen. Methicillin-resistant Staphylococcus aureus (MRSA) infections pose significant and challenging therapeutic difficulties. MRSA …
Ciprofloxacin is an alternative to vancomycin for treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections. The objective of this study was to optimization of …
S Taghiloo, G Ghajari, Z Zand… - Chemistry & …, 2023 - Wiley Online Library
Nanoparticles (NPs) may help treat multidrug‐resistant Staphylococcus aureus (MDR). This study prepared and evaluated chitosan/alginate‐encapsulated Echinacea angustifolia …
A variety of new compounds containing two or three biologically active imidazolidine-2, 4- dione and thiazolidine-2, 4-dione (TZD) cores through two-and three-way optimization of 3 …
M Samir, M Ramadan, MH Abdelrahman… - Bioorganic & Medicinal …, 2022 - Elsevier
A series of ciprofloxacin-uracil conjugates 5a-t were synthesized and identified by 1 H NMR, 13 C NMR, mass spectroscopy and elemental analyses. The antibacterial results revealed …
Fluoroquinolones have been studied for more than half a century. Since the 1960s, four generations of these synthetic antibiotics have been created and successfully introduced …
YM Ibrahim, AM Abouwarda, T Nasr, FA Omar… - Microbial …, 2020 - Elsevier
Management of infections caused by methicillin-resistant Staphylococcus aureus (MRSA) is still challenging. We herein report the antibacterial and anti-quorum sensing (anti-QS) …
I Bazine, S Bendjedid, A Boukhari - Archiv der Pharmazie, 2021 - Wiley Online Library
A series of new α‐sulfamidophosphonate/sulfonamidophosphonate (4a–n) and cyclosulfamidophosphonate (5a–d) derivatives containing the quinoline or quinolone moiety …